Techno Drugs Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 3, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Market Capitalization	3,920	3,709	-	-	-
Enterprise Value	6,296	5,999	-	-	-
Last Close Price	29.70	27.15	-	-	-
PE Ratio	19.07	15.99	-	-	-
PS Ratio	1.24	1.10	-	-	-
PB Ratio	0.96	0.92	-	-	-
P/TBV Ratio	0.96	0.92	-	-	-
P/OCF Ratio	12.62	19.62	-	-	-
EV/Sales Ratio	2.00	1.78	-	-	-
EV/EBITDA Ratio	5.82	5.70	-	-	-
EV/EBIT Ratio	9.19	8.59	-	-	-
Debt / Equity Ratio	0.67	0.65	0.87	1.04	0.97
Debt / EBITDA Ratio	2.53	2.43	2.69	3.22	2.01
Debt / FCF Ratio	-	-	32.76	-	-
Net Debt / Equity Ratio	0.58	0.54	0.75	1.01	0.90
Net Debt / EBITDA Ratio	2.25	2.07	2.39	3.22	1.90
Net Debt / FCF Ratio	-16.73	-4.55	28.35	-6.32	-1436.74
Asset Turnover	0.43	0.49	0.58	0.48	-
Inventory Turnover	1.81	1.96	2.34	1.99	-
Quick Ratio	1.91	1.07	0.72	0.43	0.53
Current Ratio	4.05	2.28	1.38	1.04	1.08
Return on Equity (ROE)	5.11%	6.45%	9.73%	7.75%	-
Return on Assets (ROA)	5.78%	6.32%	6.64%	5.76%	-
Return on Invested Capital (ROIC)	8.38%	9.62%	9.66%	8.05%	14.35%
Return on Capital Employed (ROCE)	10.20%	12.10%	14.50%	13.40%	24.80%
Earnings Yield	5.24%	6.25%	-	-	-
FCF Yield	-3.62%	-12.93%	-	-	-
Dividend Yield	3.39%	3.68%	-	-	-
Payout Ratio	21.99%	21.30%	-	-	-
Buyback Yield / Dilution	-15.69%	-38.07%	-1.34%	-	-
Total Shareholder Return	-12.30%	-34.39%	-1.34%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.